Pregnancy Success Rates of Acupuncture for in Vitro Fertilization

Infertility, Female Clinical Trial

— Acupuncture  

Official title:

Clinical Effectiveness of Acupuncture to Increase Pregnancy Success Rates for Women Undergoing in Vitro Fertilization: A Randomized Controlled Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03572608
• Other study ID #: B.30.2.ATA.0.01.00/120
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 1, 2018
• Est. completion date: October 1, 2018

Study information

• Verified date: June 2018
• Source: Ataturk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the effectiveness of acupuncture on pregnancy success before embryo transfer in IVF treatment in female infertile patients. Half of participants will receive acupuncture sessions before embryo transfer, while the other half will not receive.

Description:

Acupuncture is used for many health problem all around the World. WHO reported that acupuncture can have benefit in female infertility treatment. However, there is no enough evidence about effectiveness of acupuncture treatment in the infertility.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 120
• Est. completion date: October 1, 2018
• Est. primary completion date: September 1, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 23 Years to 45 Years

Eligibility

Inclusion Criteria:

• To have unexplained infertility

• To go in vitro fertilization treatment

• To give permission by informed consent form

Exclusion Criteria:

• Below age of 18 and above age of 45

• To have secondary infertility

• To reject completing informed consent form

Related Conditions & MeSH terms

• Infertility
• Infertility, Female

Intervention

Other:
• Acupuncture treatment
Classical acupuncture points will be used without a formal traditional Chinese medicine diagnosis in the intervention group. Neither manual needle stimulation nor moxibustion will used. The needles will left in place for 30 min and de qi was not sought. The points will be selected bilateral Heart-7, bilateral Large Intestine-4, Governing Vessel-20 and ear shenmen for the first session. Bilateral Conception Vessel-3,4,6, bilateral Liver-3, bilateral Stomach-30, bilateral Spleen-6, bilateral Governing Vessel-20 will be used for the second session. Bilateral Large Intestine-4, bilateral Spleen-6,9, bilateral Stomach-36 will be used for the last session. All acupuncture points will be selected and localized on the basis of the WHO Standardised Acupuncture Point Location.

Locations

Country	Name	City	State
Turkey	Ataturk University Hospital	Erzurum

Sponsors (1)

Lead Sponsor	Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pregnancy	positive betaHCG	2 weeks after the treatment
Secondary	Anxiety level	STAI-1 Inventory	Through study completion, 2 weeks after the protocol